Press release
Persistent Epithelial Defect Market Projected to Grow at 7.4% CAGR, Reaching USD 1.05 Billion by 2034
Persistent Epithelial Defect Market
Persistent epithelial defects (PEDs) are corneal wounds that fail to heal within the expected timeframe despite conventional treatment. These defects are caused by various underlying conditions such as neurotrophic keratopathy, severe dry eye, trauma, chemical burns, or post-surgical complications. If left untreated, PEDs can progress to corneal ulcers, scarring, and even permanent vision loss, making them a serious ophthalmic concern.
The complexity of PED treatment lies in addressing not only the defect itself but also the underlying pathology. Over the years, management has evolved from lubricants and therapeutic contact lenses to amniotic membrane transplants, autologous serum eye drops, growth factor-based therapies, and regenerative medicine approaches. With innovation in ocular surface disease research and growing adoption of advanced biologics, the PED market is set to expand steadily over the coming decade.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72290
Market Overview
• Market Size (2024): USD 510 million
• Forecast (2034): USD 1.05 billion
• CAGR (2024-2034): ~7.4%
Key Highlights:
• Rising prevalence of ocular surface diseases, diabetes, and post-surgical complications contributing to PED incidence.
• Increasing adoption of regenerative therapies such as amniotic membranes, nerve growth factors, and serum-based eye drops.
• Expanding innovation in sustained-release drug delivery for ocular healing.
• Growing collaborations between ophthalmology specialists and biotech firms advancing corneal regeneration.
Leading Players: Dompé Farmaceutici, Johnson & Johnson Vision, Alcon, Bausch + Lomb, Allergan (AbbVie), Regeneron Pharmaceuticals, Santen Pharmaceutical, and biotech innovators focusing on regenerative ophthalmology.
Key Drivers: Aging populations, increased ocular surgeries, and innovation in regenerative medicine.
Key Challenges: High treatment costs, limited access in emerging economies, and delayed diagnosis in primary care settings.
Segmentation Analysis
By Product
• Artificial Tears & Lubricants
• Amniotic Membrane Transplants
• Autologous Serum & Platelet-Rich Plasma Eye Drops
• Nerve Growth Factor (NGF) & Regenerative Therapies
• Bandage & Therapeutic Contact Lenses
• Others (experimental stem cell therapies, biosimilars)
By Platform
• Prescription Pharmaceuticals
• Biologics & Regenerative Medicine Products
• Diagnostic & Imaging Platforms
• Surgical/Transplantation Solutions
By Technology
• Growth Factor & Nerve Repair Agents
• Amniotic Membrane & Tissue Engineering
• Stem Cell & Regenerative Approaches
• Advanced Drug Delivery Systems (sustained-release implants, gels)
• AI-Based Corneal Imaging & Diagnostics
By End Use
• Hospitals
• Ophthalmology Clinics
• Ambulatory Surgical Centers
• Research Institutes & Academic Centers
By Application
• Neurotrophic Keratopathy-Associated PED
• Post-Surgical PED (LASIK, corneal grafts, cataract surgery)
• Trauma- or Burn-Induced PED
• Severe Dry Eye-Related PED
• Clinical Research & Experimental Therapies
Summary: The PED market is transitioning from traditional supportive care (lubricants, bandage lenses) toward regenerative biologics and tissue engineering, with NGF-based therapies and amniotic membranes showing the most promise in long-term healing outcomes.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72290/persistent-epithelial-defect-market
Regional Analysis
North America
• Largest market, supported by advanced ophthalmology infrastructure and availability of regenerative therapies.
• U.S. FDA approvals for biologics such as cenegermin (NGF therapy) boosting adoption.
• Strong presence of biotech innovators and clinical research centers.
Europe
• Germany, UK, France, and Italy leading in regenerative ophthalmology research.
• High adoption of amniotic membranes and serum-based therapies.
• EU orphan drug designations encouraging innovation in rare corneal disorders.
Asia-Pacific
• Fastest-growing region, driven by rising prevalence of diabetes and ocular trauma in China and India.
• Japan and South Korea leading in stem cell research and regenerative corneal therapies.
• Expanding access to advanced diagnostics and surgical solutions.
Middle East & Africa
• GCC countries investing in specialty ophthalmology centers.
• Limited adoption of regenerative therapies in Africa due to cost barriers.
• Growing medical tourism for corneal treatments in the Middle East.
Latin America
• Brazil and Mexico emerging as key regional markets.
• Expanding infrastructure for ocular surface disease treatment.
• Rising demand for cost-effective biologics and transplant solutions.
Summary: North America and Europe currently dominate due to innovation and access to advanced therapies, while Asia-Pacific is the fastest-growing market, fueled by a high burden of diabetes, ocular trauma, and strong research investments.
Market Dynamics
Growth Drivers
1. Rising Ocular Disease Burden: Increasing prevalence of diabetes, ocular trauma, and post-surgical complications.
2. Advances in Regenerative Medicine: NGF therapy, amniotic membranes, and stem cell approaches showing promising outcomes.
3. Regulatory Incentives: Orphan drug designations and rare disease funding accelerating innovation.
4. Improved Diagnostics: AI-assisted corneal imaging enabling earlier detection and personalized treatment.
Challenges
1. High Treatment Costs: Biologics and regenerative therapies remain expensive.
2. Access Inequality: Limited availability of advanced solutions in developing economies.
3. Misdiagnosis: PED often mistaken for simple dry eye, delaying effective treatment.
4. Limited Long-Term Data: Need for more clinical evidence on emerging therapies.
Latest Trends
• NGF-Based Therapies: Expanding applications in neurotrophic keratopathy-related PED.
• Stem Cell & Tissue Engineering: Research into corneal endothelial and epithelial regeneration.
• Sustained-Release Delivery Systems: Longer-lasting formulations reducing treatment burden.
• AI-Driven Diagnostics: Automated corneal imaging for accurate PED monitoring.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72290
Competitor Analysis
Major Players:
• Dompé Farmaceutici (cenegermin for neurotrophic keratopathy)
• Johnson & Johnson Vision
• Alcon Inc.
• Bausch + Lomb
• Allergan (AbbVie Inc.)
• Regeneron Pharmaceuticals
• Santen Pharmaceutical
• CorneaGen (transplant & tissue engineering)
• Emerging biotech startups in stem cell and regenerative medicine
Competitive Dynamics:
The PED market is innovation-driven, with regenerative therapies such as NGF-based eye drops and amniotic membrane transplants transforming treatment approaches. Large pharma companies dominate supportive therapies, while biotech innovators focus on novel biologics, stem cell treatments, and AI diagnostics. Strategic collaborations and licensing deals are common as companies aim to expand their ocular surface disease portfolios.
Conclusion
The persistent epithelial defect (PED) market is projected to grow from USD 510 million in 2024 to USD 1.05 billion by 2034, at a CAGR of ~7.4%. Growth will be fueled by the rising burden of ocular surface diseases, adoption of regenerative therapies, and technological advancements in diagnostics and drug delivery.
While challenges such as high costs, misdiagnosis, and access inequality persist, the long-term outlook is highly positive. With innovations in NGF therapy, stem cell research, amniotic membrane transplants, and AI imaging, the PED market is set for transformative growth.
This report is also available in the following languages : Japanese (持続性上皮欠損市場), Korean (지속성 상피 결손 시장), Chinese (持续性上皮缺损市场), French (Marché des défauts épithéliaux persistants), German (Markt für anhaltende Epitheldefekte), and Italian (Mercato dei difetti epiteliali persistenti), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72290
Our More Reports:
Major Depressive Disorder Market
https://exactitudeconsultancy.com/reports/72092/major-depressive-disorder-market
Lambert-Eaton Myasthenic Syndrome (LEMS) Market
https://exactitudeconsultancy.com/reports/72090/lambert-eaton-myasthenic-syndrome-lems-market
Complex Regional Pain Syndrome (CRPS) Market
https://exactitudeconsultancy.com/reports/72088/complex-regional-pain-syndrome-crps-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Persistent Epithelial Defect Market Projected to Grow at 7.4% CAGR, Reaching USD 1.05 Billion by 2034 here
News-ID: 4193995 • Views: …
More Releases from Exactitude Consultancy
Wet Age-Related Macular Degeneration Market Expected to Grow at 7.0% CAGR
Introduction
Wet age-related macular degeneration (wet AMD) is a progressive eye disorder characterized by abnormal blood vessel growth under the macula, leading to fluid leakage, scarring, and central vision loss. It is a leading cause of blindness in individuals over the age of 60. Unlike dry AMD, which progresses more slowly, wet AMD can cause rapid vision deterioration, making timely diagnosis and treatment critical.
Over the past two decades, the introduction of…
Neurotrophic Keratopathy Market is expected to reach USD 540 million by 2034
Neurotrophic keratopathy (NK) is a rare, degenerative corneal disease caused by impaired corneal innervation, leading to reduced or absent corneal sensitivity. It results in epithelial breakdown, impaired healing, corneal ulceration, and in severe cases, vision loss. Common causes include herpes simplex/zoster infection, diabetes, ocular surgery, multiple sclerosis, and trigeminal nerve damage.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72289
With the rising incidence of ocular surgeries, viral infections, and diabetes,…
Neuropathic Ocular Pain Market Forecast to Grow at 7.5% CAGR, Reaching USD 890 M …
Introduction
Neuropathic ocular pain (NOP) is a complex and underdiagnosed condition characterized by chronic eye pain stemming from dysfunction or damage within the ocular sensory nerves. Unlike traditional ocular surface disorders, NOP persists even in the absence of visible signs of inflammation or tissue damage, making it particularly challenging to diagnose and treat. Patients often report severe burning, stinging, or stabbing eye pain, which can significantly impair daily activities, sleep, and…
Retinal Vein Occlusion (RVO) Market is expected to reach USD 4.3 billion by 2034
Retinal vein occlusion (RVO) is the second most common retinal vascular disorder after diabetic retinopathy. It occurs when a blockage develops in the veins that carry blood away from the retina, leading to vision impairment, macular edema, and in some cases, retinal ischemia or neovascularization.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72291
The condition is classified into branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO). Risk…
More Releases for PED
Ped-Lock Valves & Fittings
• Company Overview
Established in 1985, Ped Lock is ISO 9001:2015-certified and manufactures a wide range of instrumentation valves, fittings, and hydraulic components.
• Product Portfolio
Includes needle, ball, check, gate, globe, safety/relief, manifold, condensate pot, quick release valves, air headers, hydraulic hose, and more.
• Certifications & Quality Assurance
Equipped with advanced machining, in-house R&D and labs, and rigorous testing (leakage, hydro, helium, seismic, etc.).
• Global Presence
Products are exported worldwide, including to the USA, UK, Germany, Australia, and…
Persistent Epithelial Defect Market Size is Set for Rapid Growth as Innovative T …
The Persistent Epithelial Defect market size is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as Dompe Farmaceutici, Amber Ophthalmics, Kala Bio, Kiora Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Amber Ophthalmics, Inc., Noveome Biotherapeutics, formerly Stemnion, Amber Ophthalmics, Inc.
[Nevada, United States] - DelveInsight's "Persistent Epithelial Defect Market Insights, Epidemiology, and Market Forecast 2034." report offers a…
diaphragm accumulator, bladder accumulator ,ball valve, bladder
Siken Hydraulics Inc. has a team of industry experts with experiences over 20 years ,who are always willing to serve the clients all the time. We could design and offer our hydraulic accumulator, pulsation dampeners, compensators according to different standards such as ASME, CE/PED etc.to meet our customers' diverse needs for our products.
We are providing the piston accumumulator from 0.1L to 500L and operating pressures up to 20,000…
Foot Care Medicated Creams Market Upcoming Trends, Segmented by Type, Applicatio …
New Jersey, United States,- Mr Accuracy Reports published new research on Global Foot Care Medicated Creams covering micro level of analysis by competitors and key business segments (2022-2029). The Global Foot Care Medicated Creams explores comprehensive study on various segments like opportunities, size, development, innovation, sales and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists both qualitative and quantitative…
Pipeline Embolization Device (PED) Market Emerging Trends, Growth Factors, Regio …
Los Angeles-United State: QY Research has recently published a research report titled, "Global Pipeline Embolization Device (PED) Market Report, History and Forecast 2017-2028, Breakdown Data by Companies, Key Regions, Types and Application" assessing various factors impacting its trajectory. The global Pipeline Embolization Device (PED) market report offers a high-quality, accurate, and comprehensive research study to equip players with valuable insights for making strategic business choices. The research analysts have provided…
Strongly Increasing Market of Gas Scooter Market Report 2019-2025: Top Key Playe …
UpMarketResearch offers a latest published report on “Global Gas Scooter Market Analysis and Forecast 2018-2025” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 113 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
Get Exclusive FREE Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/49493
Gas Scooter Market research report delivers a close…
